According to the report, the Size of the Bioseparation Systems Market in Europe is valued at USD xx Million in 2019 and is projected to reach USD xx Million by 2024, growing at a CAGR of xx.x% during the forecast period 2019-2024.
Bioseparation refers to separation and purification of products of a biochemical reaction. Membrane, filters and chromatography are some of the most common techniques used to separate particles.
The significant drivers are growing demand for biopharmaceuticals and advancements in technology. Also increasing awareness due to biosimilars and government initiatives are also boosting this industry. Strict regulations regarding Bioseparation Systems is major restraint limiting the industry.
Europe Bioseparation Systems Market has been segmented and sub-segmented into the following categories
On the basis of type, the chromatography technique has the largest market share.
On the basis of Application, the Biopharmaceutical systems are the most widely used.
On the basis of region, Europe is assumed as developed market and is anticipated to witness significant growth in the forecast period.
Prominent Companies dominating the Europe Bioseparation Systems Market Profiled in the Report are GE Healthcare Life Sciences, Sartorius AG, US Filter Control Systems, Inc., Asahi Kasei Corporation, Pall Corporation, Agilent Technologies, Waters Corporation, 3M Company, Merck Millipore, Bio-Rad Laboratories, Inc. and Dow Chemical Company.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Biopreservation Equipment
5.1.2.1 Temperature Control Systems
5.1.2.1.1 Freezers
5.1.2.1.2 Cryogenic Storage Systems
5.1.2.1.3 Thawing Equipment
5.1.2.1.4 Refrigerators
5.1.2.2 Accessories
5.1.2.3 Alarms & Monitoring Systems
5.1.2.4 Incubators
5.1.2.5 Centrifuges
5.1.2.6 Other Equipment
5.1.3 Biopreservation Media
5.1.3.1 Nutrient Media
5.1.3.2 Sera
5.1.3.3 Growth Factors and Supplements
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Biospecimen
5.2.1 Introduction
5.2.2 Human Tissue Samples
5.2.3 Organs
5.2.4 Stem Cells
5.2.5 Other Biospecimens
5.2.6 Y-o-Y Growth Analysis, By Biospecimen
5.2.7 Market Attractiveness Analysis, By Biospecimen
5.2.8 Market Share Analysis, By Biospecimen
5.3 Application
5.3.1 Introduction
5.3.2 Therapeutic Applications
5.3.3 Research Applications
5.3.4 Clinical Trials
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End Users
5.4.1 Introduction
5.4.2 Biobanks
5.4.3 Gene Banks
5.4.4 Hospitals
5.4.5 Other End Users
5.4.6 Y-o-Y Growth Analysis, By End Users
5.4.7 Market Attractiveness Analysis, By End Users
5.4.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Biospecimen
6.1.3.4 By Application
6.1.3.5 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Biospecimen
6.1.4.4 By Application
6.1.4.5 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Biospecimen
6.1.5.4 By Application
6.1.5.5 By End Users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare Life Sciences
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Pall Corporation
8.3 3M Company
8.4 Waters Corporation
8.5 Asahi Kasei Corporation
8.6 Merck Millipore
8.7 Sartorius AG
8.8 Agilent Technologies
8.9 Bio-Rad Laboratories, Inc.
8.10 Dow Chemical Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
